Search
for

    Sort by

    Research 241–270 of 1000+

    1. Can the golden nutraceutical frankincense combat COVID‐19? Future postharvest and food · 2024
    2. Adiantum capillus-veneris Linn (Maidenhair fern) extract-based drug as a symptomatic treatment for COVID-19. (clinical candidate) 2020
    3. Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial BMC Pharmacology and Toxicology · 2023
    4. Egyptian Traditional Herbal Medicine Candidate Adiantum Capillus-Veneris Linn. as a Symptomatic Treatment for COVID-19: A Review of its Mechanisms, Pros and Cons. 2021
    5. Risk factors associated with development and persistence of long COVID bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 8 citations
    6. Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis Frontiers in Immunology · 2022 · 17 citations
    7. Online search interest in long-term symptoms of coronavirus disease 2019 during the COVID-19 pandemic in Japan: Infodemiology study using the most visited search engine in Japan PLoS ONE · 2023 · 4 citations
    8. The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review Current Dermatology Reports · 2022 · 2 citations
    9. Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak Viruses · 2020 · 170 citations
    10. Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial Cureus · 2021 · 41 citations
    11. Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection Molecules · 2022 · 14 citations
    12. Antiviral and Anti-Inflammatory Plant-Derived Bioactive Compounds and Their Potential Use in the Treatment of COVID-19-Related Pathologies Journal of Xenobiotics · 2022 · 26 citations
    13. Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity Human Genomics · 2023 · 9 citations
    14. Trends in dermatological presentations at the emergency department of a tertiary hospital in Singapore: a 4-year analysis pre- and during COVID-19 International Journal of Emergency Medicine · 2025
    15. Covid induced telogen effluvium (CITE): An insight Indian Dermatology Online Journal · 2022 · 4 citations
    16. Polycystic ovary syndrome and its management: In view of oxidative stress BioMolecular Concepts · 2024 · 35 citations
    17. GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects Frontiers in Endocrinology · 2021 · 59 citations
    18. Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1 Journal of clinical immunology · 2023 · 2 citations
    19. Dermatologic Changes in Experimental Model of Long COVID Microorganisms · 2024 · 1 citations
    20. Exploring links between acne and metabolic syndrome: a narrative review Open Medicine · 2025
    21. The necessity of investigations to clarify sex and racial disparities in pathophysiology of Long COVID Hypertension research · 2024
    22. Reexamining the Role of Diet in Dermatology Cutis · 2021
    23. Performance of an interferon-γ release assay-based test for cell-mediated immunity to SARS-CoV-2 Frontiers in Immunology · 2023 · 3 citations
    24. Ex vivo detection of SARS CoV 2 spike protein in human hair follicles and potential link to telogen effluvium Scientific Reports · 2025
    25. SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients Frontiers in Immunology · 2022
    26. Dupilumab in Inflammatory Skin Diseases: A Systematic Review Biomolecules · 2023 · 72 citations
    27. Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study 2021 · 56 citations
    28. Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection JAMA Network Open · 2022 · 95 citations
    29. SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism Viruses · 2021 · 50 citations
    30. Telogen effluvium related to post severe Sars‐Cov‐2 infection: Clinical aspects and our management experience Dermatologic Therapy · 2020 · 35 citations